Table 1.

Consumption of parenteral antimicrobials as a total and by Anatomical Therapeutic Chemical group in a hospital in Saudi Arabia, 2006–2008.

	DDD per 100 bed-days			% change 2008 vs. 2006	P
	2006	2007	2008
J01CA01 ampicillin parenteral	0.85	1.485	1.19	40.0	.64
J01CE01 benzylpenicillin parenteral	0.826	0.933	0.928	12.3	.36
J01CF04 oxacillin (parenteral)	0.404	1.193	0.93	130.2	.54
J01CR02 amoxicillin and enzyme inhibitor (parenteral)	0.113	0.203	0.108	−4.4	.97
J01CR03 ticarcillin and enzyme inhibitor	0.604	1.424	1.329	120.0	.40
J01CR05 pipracillin and enzyme inhibitor	0.064	0.025	0.202	215.6	.46
J01DB02 cefazolin	3.942	6.432	6.166	56.4	.39
J01DC01 cefoxitin (parenteral)	0.957	1.696	1.353	41.4	.64
J01DC02 cefuroxime (parenteral)	0.67	1.319	1.194	78.2	.45
J01DD01 cefotaxime	0.067	0.065	0.174	159.7	.34
J01DD04 ceftriaxone	7.274	8.363	7.447	2.4	.90
J01DD09 ceftazidime	1.1	3.086	1.259	14.5	.95
J01DE01 cefepime	0.149	0.151	0.827	455.0	.33
J01DF01 aztreonam	0.012	0.062	0.055	358.3	.416
J01DH02 meropenem	0.161	0.096	0.492	205.6	.43
J01DH51 imipenem and enzyme inhibitor	3.93	4.901	5.234	33.2	.17
J01EE01 trimethoprim-sulfamethoxazole (parenteral)	0.049	0.03	0.563	1049.0	.35
J01FA01 erythromycin (parenteral)	0.07	0.137	0.091	30.0	.80
J01FA10 azithromycin (parenteral)	0.378	0.155	0.159	−57.9	.34
J01FF01 clindamycin (parenteral)	0.384	0.407	0.559	45.6	.25
J01GB03 gentamicin (parenteral)	0.965	1.846	2.107	118.3	.19
J01GB06 amikacin	0.195	0.463	0.325	66.7	.67
J01MA02 ciprofloxacin (parenteral)	3.55	68.77	82.643	2228.0	.23
J01MA12 levofloxacin (parenteral)	0.588	2.491	3.188	442.2	.19
J01XA01 vancomycin (parenteral)	1.422	2.536	2.97	108.9	.23
J01XB02 polymyxin B (parenteral)	0.428	0.74	0.7	63.6	.20
J01XD01 metronidazole (parenteral)	0.009	0.017	0.018	100.0	.23